AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24862085 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary intervention programme (dietary advice, exercise sessions, psychological counselling for parents)
Number of subjects: 75
Study 24862085 — intervention group
Group type: COMPARATOR
Intervention: Standard care programme (providing healthy lifestyle advice)
Number of subjects: 75
Study 24862085 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined groups (intervention and control)
Number of subjects: 75
Study 23437496 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI)
Number of subjects: 60
Study 23437496 — intervention group
Group type: COMPARATOR
Intervention: Health promotion program (HPP)
Number of subjects: 60
Study 19402190 — intervention group
Group type: EXPERIMENTAL
Intervention: Anal fistula plug
Number of subjects: 31
Study 19402190 — intervention group
Group type: COMPARATOR
Intervention: Endorectal advancement flap
Number of subjects: 31
Study 17925589 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan 60-240 mg (study 1)
Number of subjects: 17
Study 17925589 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan 180-480 mg (study 2)
Number of subjects: 17
Study 17925589 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matching placebo for both studies)
Number of subjects: 17
Study 15130073 — intervention group
Group type: EXPERIMENTAL
Intervention: Bonded amalgam sealants
Number of subjects: 0
Study 15130073 — intervention group
Group type: COMPARATOR
Intervention: Resin-based pit-and-fissure sealants
Number of subjects: 0
Study 11702012 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (ribavirin + interferon-alpha)
Number of subjects: 51
Study 8988921 — intervention group
Group type: EXPERIMENTAL
Intervention: Guar wheat bread
Number of subjects: 11
Study 8988921 — intervention group
Group type: COMPARATOR
Intervention: Control wheat bread
Number of subjects: 11
Study 8483846 — intervention group
Group type: EXPERIMENTAL
Intervention: Procaterol (oral administration)
Number of subjects: 0
Study 8483846 — intervention group
Group type: EXPERIMENTAL
Intervention: Procaterol (tablet administration)
Number of subjects: 0
Study 3120928 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cyclosporin (5 mg/kg/day) for 12 weeks
Number of subjects: 19
Study 3120928 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 3120928 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-treatment observation
Number of subjects: 19
Study 28153504 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil-enriched enteral nutrition (FO-EN)
Number of subjects: 92
Study 28153504 — intervention group
Group type: COMPARATOR
Intervention: Low-fat enteral nutrition (LF-EN)
Number of subjects: 92
Study 27611703 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g/kg/week IVIG (Arm A)
Number of subjects: 69
Study 27611703 — intervention group
Group type: COMPARATOR
Intervention: 1 g/kg/week IVIG + 0.5 mg/kg/day prednisone (Arm B)
Number of subjects: 69
Study 24716215 — intervention group
Group type: EXPERIMENTAL
Intervention: telbivudine (LdT)
Number of subjects: 88
Study 24716215 — intervention group
Group type: COMPARATOR
Intervention: entecavir (ETV)
Number of subjects: 88
Study 24716215 — intervention group
Group type: EXPERIMENTAL
Intervention: telbivudine (LdT) and entecavir (ETV)
Number of subjects: 88
Study 22118418 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage-matched smoking cessation counselling intervention
Number of subjects: 1860
Study 22118418 — intervention group
Group type: COMPARATOR
Intervention: Brief counselling on healthy diet
Number of subjects: 1860
Study 20864862 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency, low-magnitude vibration (30 Hz, 0.3 g peak acceleration) for 10 min/day for 6 months
Number of subjects: 31
Study 20864862 — intervention group
Group type: COMPARATOR
Intervention: Standing on the floor without the platform for 6 months
Number of subjects: 31
Study 19074232 — intervention group
Group type: COMPARATOR
Intervention: Exercise prescription
Number of subjects: 579
Study 19074232 — intervention group
Group type: COMPARATOR
Intervention: Six lessons in Alexander technique
Number of subjects: 579
Study 19074232 — intervention group
Group type: EXPERIMENTAL
Intervention: Six lessons in Alexander technique combined with exercise
Number of subjects: 579
Study 19074232 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 lessons in Alexander technique plus exercise
Number of subjects: 579
Study 19074232 — intervention group
Group type: COMPARATOR
Intervention: Normal care (control)
Number of subjects: 579
Study 15785148 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythm control
Number of subjects: 3091
Study 15785148 — intervention group
Group type: COMPARATOR
Intervention: Rate control
Number of subjects: 3091
Study 14660460 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005% monotherapy once daily for 6 months
Number of subjects: 466
Study 14660460 — intervention group
Group type: COMPARATOR
Intervention: Dual ocular hypotensive therapy
Number of subjects: 466
Study 11014754 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dimensional dynamic posture prediction model
Number of subjects: 10
Study 11014754 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized model with parameter values statistically synthesized
Number of subjects: 10
Study 8783335 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 micrograms octreotide t.i.d. for 3 days
Number of subjects: 60
Study 8783335 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 60
Study 1292337 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuprophan (Cu) hemodialysis
Number of subjects: 12
Study 1292337 — intervention group
Group type: COMPARATOR
Intervention: Hemophan (He) hemodialysis
Number of subjects: 12
Study 1292337 — intervention group
Group type: COMPARATOR
Intervention: Polysulfone (PS) hemodialysis
Number of subjects: 12
Study 6422828 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% sodium cromoglycate eyedrops
Number of subjects: 41
Study 6422828 — intervention group
Group type: COMPARATOR
Intervention: Placebo eyedrops
Number of subjects: 41
Study 31169029 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-assisted therapy from a family member trained by a physiotherapist
Number of subjects: 35
Study 31169029 — intervention group
Group type: COMPARATOR
Intervention: Usual physiotherapy care
Number of subjects: 35
Study 29954931 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone/sirolimus
Number of subjects: 138
Study 29954931 — intervention group
Group type: COMPARATOR
Intervention: Prednisone/sirolimus/calcineurin-inhibitor
Number of subjects: 138
Study 26788880 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 0
Study 26788880 — intervention group
Group type: EXPERIMENTAL
Intervention: First OPV vaccination
Number of subjects: 0
Study 26788880 — intervention group
Group type: EXPERIMENTAL
Intervention: DTP-Hib-HepB vaccination
Number of subjects: 0
Study 24393019 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive game (computer game)
Number of subjects: 190
Study 24393019 — intervention group
Group type: COMPARATOR
Intervention: Information brochure
Number of subjects: 190
Study 24393019 — intervention group
Group type: COMPARATOR
Intervention: Narrative story
Number of subjects: 190
Study 22762695 — intervention group
Group type: EXPERIMENTAL
Intervention: Power Balance Silicone Wristband (PBB)
Number of subjects: 20
Study 22762695 — intervention group
Group type: COMPARATOR
Intervention: Silicone band
Number of subjects: 20
Study 22762695 — intervention group
Group type: COMPARATOR
Intervention: Deactivated PBB
Number of subjects: 20
Study 22762695 — intervention group
Group type: COMPARATOR
Intervention: No band
Number of subjects: 20
Study 20032790 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (IIT) - maintenance of blood glucose between 80 mg/dL and 110 mg/dL with continuous insulin infusion
Number of subjects: 88
Study 20032790 — intervention group
Group type: COMPARATOR
Intervention: Conventional glycemic therapy (CGT) - maintenance of blood glucose below 180 mg/dL with subcutaneous insulin and insulin infusion if blood glucose levels exceeded 220 mg/dL
Number of subjects: 88
Study 20032790 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (IIT)
Number of subjects: 88
Study 20032790 — intervention group
Group type: COMPARATOR
Intervention: Conventional glycemic therapy (CGT)
Number of subjects: 88
Study 17434547 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐leptin
Number of subjects: 24
Study 17434547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 17434547 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study 15775711 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (American Stroke Association, 30-slide stroke awareness lecture)
Number of subjects: 104
Study 11939911 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-drug multimodal regimen (dexamethasone 4 mg, ondansetron 4 mg, droperidol 1.25 mg, metoclopramide 10 mg i.v.)
Number of subjects: 180
Study 11939911 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose propofol infusion (1 mg/kg/h during the operation and the first 4 postoperative hours)
Number of subjects: 180
Study 11939911 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prophylaxis)
Number of subjects: 180
Study 11939911 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-drug multimodal regimen (M group)
Number of subjects: 180
Study 11939911 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose propofol infusion (P group)
Number of subjects: 180
Study 11939911 — intervention group
Group type: COMPARATOR
Intervention: Control group (C group)
Number of subjects: 180
Study 9830641 — intervention group
Group type: EXPERIMENTAL
Intervention: Inferior alveolar nerve block + intraosseous injection (0.9 mL of 2% lidocaine with 1:100,000 epinephrine)
Number of subjects: 38
Study 9830641 — intervention group
Group type: COMPARATOR
Intervention: Inferior alveolar nerve block + mock intraosseous injection
Number of subjects: 38
Study 7855093 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea
Number of subjects: 10
Study 7855093 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular black tea
Number of subjects: 10
Study 7855093 — intervention group
Group type: EXPERIMENTAL
Intervention: Decaffeinated black tea
Number of subjects: 10
Study 7855093 — intervention group
Group type: COMPARATOR
Intervention: No tea
Number of subjects: 10
Study 2507027 — intervention group
Group type: EXPERIMENTAL
Intervention: salcatonin 100 IU intranasally
Number of subjects: 52
Study 2507027 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 52
Study 1105543 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluphenazine 0.5 mg/nortriptyline 10 mg three times daily
Number of subjects: 62
Study 1105543 — intervention group
Group type: COMPARATOR
Intervention: Promazine 50 mg three times daily
Number of subjects: 62
Study 31359633 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperoxic sprint interval training (HST, 60% oxygen)
Number of subjects: 18
Study 31359633 — intervention group
Group type: COMPARATOR
Intervention: Normoxic sprint interval training (NST)
Number of subjects: 18
Study 29105476 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive sensibility reflexotherapy by tendon acupuncture at trigger points
Number of subjects: 79
Study 29105476 — intervention group
Group type: COMPARATOR
Intervention: Traditional traction, massage and intermediate frequency electro therapy
Number of subjects: 79
Study 25847557 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupressure for 10 weeks
Number of subjects: 150
Study 25847557 — intervention group
Group type: COMPARATOR
Intervention: Routine care for 10 weeks
Number of subjects: 150
Study 22615029 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of the Resident Assessment Instrument (RAI) into home care services
Number of subjects: 0
Study 22615029 — intervention group
Group type: COMPARATOR
Intervention: Control group (no RAI implementation)
Number of subjects: 0
Study 21640198 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon‐α for 24 weeks
Number of subjects: 505
Study 19029171 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion
Number of subjects: 1253
Study 19029171 — intervention group
Group type: COMPARATOR
Intervention: Routine glucose lowering therapy
Number of subjects: 1253
Study 16981921 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonfluoroscopic navigation system (Ensite NavX)
Number of subjects: 80
Study 16981921 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopic guidance only
Number of subjects: 80
Study 15365658 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 IU calcitonin nasal spray with calcium (500 mg) and vitamin D (200 IU)
Number of subjects: 98
Study 15365658 — intervention group
Group type: COMPARATOR
Intervention: Calcium (500 mg) and vitamin D (200 IU) alone
Number of subjects: 98
Study 15365658 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 IU calcitonin nasal spray
Number of subjects: 98
Study 10604338 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-core biopsy
Number of subjects: 160
Study 10604338 — intervention group
Group type: COMPARATOR
Intervention: 6-core biopsy
Number of subjects: 160
Study 9377132 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic saline (crystalloid)
Number of subjects: 102
Study 9377132 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% albumin (colloid)
Number of subjects: 102
Study 1544845 — intervention group
Group type: EXPERIMENTAL
Intervention: BW12C (20 mg/kg to 50 mg/kg) with mitomycin C
Number of subjects: 18
Study 1544845 — intervention group
Group type: EXPERIMENTAL
Intervention: BW12C (maintenance infusion of 4-6 mg/kg/hr) with mitomycin C
Number of subjects: 18
Study 1544845 — intervention group
Group type: EXPERIMENTAL
Intervention: BW12C
Number of subjects: 18
Study 3886567 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunflower oil (linoleic acid 66%; n = 6)
Number of subjects: 10
Study 3886567 — intervention group
Group type: COMPARATOR
Intervention: Olive oil (linoleic acid 4%; n = 4)
Number of subjects: 10
Study 3297468 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinacidil
Number of subjects: 37
Study 3297468 — intervention group
Group type: COMPARATOR
Intervention: Hydralazine
Number of subjects: 37
Study 31912695 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote limb ischemic conditioning
Number of subjects: 104
Study 31912695 — intervention group
Group type: COMPARATOR
Intervention: Control (standard treatment)
Number of subjects: 104
Study 29016558 — intervention group
Group type: EXPERIMENTAL
Intervention: Insure FIT
Number of subjects: 1006
Study 29016558 — intervention group
Group type: EXPERIMENTAL
Intervention: OC FIT-CHEK
Number of subjects: 1006
Study 29016558 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoccult II SENSA
Number of subjects: 1006
Study 29016558 — intervention group
Group type: COMPARATOR
Intervention: Insure FIT vs OC FIT-CHEK
Number of subjects: 1006
Study 29016558 — intervention group
Group type: COMPARATOR
Intervention: Insure FIT vs Hemoccult II SENSA
Number of subjects: 1006
Study 29016558 — intervention group
Group type: EXPERIMENTAL
Intervention: All tests
Number of subjects: 1006
Study 24795163 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS + TRTT
Number of subjects: 37
Study 24795163 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo TENS + TRTT
Number of subjects: 37
Study 24795163 — intervention group
Group type: COMPARATOR
Intervention: Control without active training
Number of subjects: 37
Study 23128129 — intervention group
Group type: EXPERIMENTAL
Intervention: Veloderm (crystalline cellulose membrane)
Number of subjects: 96
Study 23128129 — intervention group
Group type: COMPARATOR
Intervention: Vaseline gauze (control)
Number of subjects: 96
Study 21461904 — intervention group
Group type: COMPARATOR
Intervention: Heavyweight mesh (HW)
Number of subjects: 600
Study 21461904 — intervention group
Group type: EXPERIMENTAL
Intervention: Middleweight mesh (MW)
Number of subjects: 600
Study 21461904 — intervention group
Group type: EXPERIMENTAL
Intervention: Lightweight composite polypropylene mesh (LW)
Number of subjects: 600
Study 21461904 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanised lightweight mesh (TLW)
Number of subjects: 600
Study 17964764 — intervention group
Group type: EXPERIMENTAL
Intervention: Soleduc psycho-educational program (7 sessions, 1 hour each)
Number of subjects: 220
Study 17964764 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-specific psychosocial training)
Number of subjects: 220
Study 17964764 — intervention group
Group type: EXPERIMENTAL
Intervention: Soleduc psycho-educational program (attendance of at least 7 modules)
Number of subjects: 220
Study 16258165 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (80 mg daily)
Number of subjects: 12
Study 16258165 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 12786622 — intervention group
Group type: EXPERIMENTAL
Intervention: Arterial embolization
Number of subjects: 0
Study 12786622 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipiodol-targeted chemoembolization
Number of subjects: 0
Study 12786622 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial injection of radioactive iodine mixed with Lipiodol
Number of subjects: 0
Study 10758415 — intervention group
Group type: EXPERIMENTAL
Intervention: Loperamide
Number of subjects: 105
Study 10758415 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 105
Study 8931220 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraportal PGE1 (250 or 500 micrograms/day for 3 days)
Number of subjects: 26
Study 8931220 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous PGE1 (720 micrograms/day for 3 days)
Number of subjects: 26
Study 8931220 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 26
Study 1576624 — intervention group
Group type: EXPERIMENTAL
Intervention: Loracarbef (200‐mg capsule BID or 15 mg/kg/day suspension)
Number of subjects: 116
Study 1576624 — intervention group
Group type: COMPARATOR
Intervention: Penicillin VK (250‐mg capsule QID or 20 mg/kg/day suspension)
Number of subjects: 116
Study 1576624 — intervention group
Group type: EXPERIMENTAL
Intervention: Loracarbef
Number of subjects: 116
Study 1576624 — intervention group
Group type: COMPARATOR
Intervention: Penicillin
Number of subjects: 116
Study 2866759 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal argon laser photocoagulation
Number of subjects: 2244
Study 2866759 — intervention group
Group type: COMPARATOR
Intervention: Deferral of photocoagulation
Number of subjects: 2244
Study 31672949 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone Application Peer Support (SAPS)
Number of subjects: 36
Study 31672949 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study 29202347 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette scavenging behavior (sharing a cigarette with a stranger, smoking a 'found' cigarette, smoking a previously used cigarette 'butt')
Number of subjects: 227
Study 29202347 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic and psychosocial factors associated with scavenging
Number of subjects: 227
Study 27555883 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensorimotor insole with a lateral pressure point
Number of subjects: 34
Study 27555883 — intervention group
Group type: COMPARATOR
Intervention: Control insole
Number of subjects: 34
Study 24837447 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily low-dose sildenafil (25 mg)
Number of subjects: 48
Study 24837447 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 22984008 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal angioplasty and stenting
Number of subjects: 224
Study 21215143 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral glucose loading alone
Number of subjects: 98
Study 21215143 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral standardized fat loading alone
Number of subjects: 98
Study 21215143 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined glucose and fat loading
Number of subjects: 98
Study 21215143 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 98
Study 18673081 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine rupture (n=21)
Number of subjects: 84
Study 18673081 — intervention group
Group type: COMPARATOR
Intervention: Non-reassuring fetal status (n=63)
Number of subjects: 84
Study 16163366 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation (HFOV)
Number of subjects: 119
Study 16163366 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation (CV)
Number of subjects: 119
Study 12200550 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation
Number of subjects: 797
Study 12200550 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation
Number of subjects: 797
Study 9584554 — intervention group
Group type: EXPERIMENTAL
Intervention: Vanceril treatment
Number of subjects: 142
Study 9584554 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study 7638805 — intervention group
Group type: EXPERIMENTAL
Intervention: DeVilbiss 40 nebuliser
Number of subjects: 13
Study 7638805 — intervention group
Group type: COMPARATOR
Intervention: DeVilbiss 45 nebuliser
Number of subjects: 13
Study 2229497 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa‐2b (1.5 x 10(6) IU) injected three times weekly for 3 weeks (cumulative dose of 13.5 million IU)
Number of subjects: 172
Study 2229497 — intervention group
Group type: COMPARATOR
Intervention: Placebo injected three times weekly for 3 weeks
Number of subjects: 172
Study 2229497 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa‐2b
Number of subjects: 172
Study 2229497 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172
Study 369645 — intervention group
Group type: EXPERIMENTAL
Intervention: Endolymphatic therapy
Number of subjects: 146
Study 369645 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 146
Study 30274756 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular hip injection (IAHI)
Number of subjects: 120
Study 30274756 — intervention group
Group type: COMPARATOR
Intervention: Fascia-iliaca compartment block (FICB)
Number of subjects: 120
Study 25727055 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy
Number of subjects: 138